The Impact of a Real-Life Inflammatory Bowel Disease Education Course for Brazilian Physicians from the Perspective of Its Participants
- 1 Department of Internal Medicine, Medical School, São Paulo State University (Unesp), Botucatu, Brazil
- 2 Department of Internal Medicine, Medical School, São Paulo State University (Unesp), Botucatu, Brazil
- 3 Department of Internal Medicine, Medical School, São Paulo State University (Unesp), Botucatu, Brazil
- 4 Department of Internal Medicine, Medical School, São Paulo State University (Unesp), Botucatu, Brazil
- 5 Department of Surgery, Medical School, São Paulo State University (Unesp), Botucatu, Brazil
- 6 Department of Internal Medicine, Medical School, São Paulo State University (Unesp), Botucatu, Brazil
Abstract
Background: Physicians must acquire the necessary skills to provide Inflammatory Bowel Disease (IBD) patients with state-of-the - art clinical care, aiming to improve patient’s quality of life and disease outcomes. Purpose: To describe the queries and experiences of doctors enrolled in an IBD education course and to evaluate the impact of the course. Methods: A retrospective study included 100 physicians, of which 78 attended the course. A questionnaire was applied evaluating how the course had an impact on their IBD-knowledge. The 20-hour-course consisted of practical “real-life” activities and theoretical discussions. Results: The majority of doctors’ expertise was in gastroenterology (53%) and coloproctology (44%). A significant portion had no experience with biological therapy for ulcerative colitis (19.4%) or Crohn’s disease (5.05%). The main topics doctors wanted to discuss were biological therapy (93%), new drugs (74%) and differential diagnosis (64%). A considerable number of physicians did not feel confident at prescribing biological therapy before the course (44.4%), a percentage that decreased to 8.5% after the course (p < 0.0001). The impact of the course was considered high (grades 9 and 10) by most of the participants (78.2%). Discussion: The ideal course should have a practical and theoretical component, as well as the support of an experienced multidisciplinary team. A real-life practical-theoretical IBD course proved a success at increasing IBD knowledge.
- Peyrin-Biroulet, L., Sandborn, W., Sands, B.E., Reinisch, W., Bemelman, W., Bryant R.V., et al. (2015) Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE): Determining Therapeutic Goals for Treat-to-Target. American Journal of Gastroenterology, 110, 1324-1338. https://doi.org/10.1038/ajg.2015.233
- Hindryckx, P., Vande Casteele, N., Novak, G., Khanna, R., D’Haens, G., Sandborn, W.J., et al. (2018) The Expanding Therapeutic Armamentarium for Inflammatory Bowel Disease: How to Choose the Right Drug [s] for Our Patients?. Journal of Crohn’s and Colitis, 12, 105-119. https://doi.org/10.1093/ecco-jcc/jjx117
- ClinicalTrials.gov [Internet]. Bethesda (MD): National Library of Medicine (US). https://clinicaltrials.gov/ct2/home
- Turner, D., Ricciuto, A., Lewis, A., D’Amico, F., Dhaliwal, J., Griffiths, A.M., et al., International Organization for the Study of IBD (2021) STRIDE-II: An Update on the Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE) Initiative of the International Organization for the Study of IBD (IOIBD): Determining Therapeutic Goals for Treat-to-Target Strategies in IBD. Gastroenterology, 160, 1570-1583. https://doi.org/10.1053/j.gastro.2020.12.031
- Sapir, T., Moreo, K., Carter, J.D., Greene, L., Patel, B. and Higgins, P.D. (2016) Continuing Medical Education Improves Gastroenterologists’ Compliance with Inflammatory Bowel Disease Quality Measures. Digestive Diseases and Sciences, 61, 1862-1869. https://doi.org/10.1007/s10620-016-4061-1
- Mao, E.J., Hazlewood, G.S., Kaplan, G.G., Peyrin-Biroulet, L., and Ananthakrishnan, A.N. (2017) Systematic Review with Meta-Analysis: Comparative Efficacy of Immunosuppressants and Biologics for Reducing Hospitalisation and Surgery in Crohn’s Disease and Ulcerative Colitis. Alimentary Pharmacology & Therapeutics, 45, 3-13. https://doi.org/10.1111/apt.13847
- Vogelaar, L., Spijker, A.V. and van der Woude, C.J. (2009) The Impact of Biologics on Health-Related Quality of Life in Patients with Inflammatory Bowel Disease. Clinical and Experimental Gastroenterolog, 2, 101-109. https://doi.org/10.2147/CEG.S4512
- Molodecky, N.A., Soon, S., Rabi, D.M., Ghali, W.A., Ferris, M., Chernoff, G., et al. (2012) Increasing Incidence and Prevalence of the Inflammatory Bowel Diseases with Time, Based on Systematic Review. Gastroenterology, 142, 46-54. https://doi.org/10.1053/j.gastro.2011.10.001
- Kaplan, G.G. and Ng, S.C. (2017) Understanding and Preventing the Global Increase of Inflammatory Bowel Disease. Gastroenterology, 152, 313-321. https://doi.org/10.1053/j.gastro.2016.10.020